Offer - Urjas Oil for just ₹ 1 X
Arvast CF Capsule DR is a commercial drug that is prescribed in the form of Capsule. Secondary and off-label uses of Arvast CF Capsule DR have also been mentioned below.
The optimal dosage of Arvast CF Capsule DR is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Arvast CF Capsule DR include Nausea or vomiting, Headache, Constipation. Some other side effects of Arvast CF Capsule DR have been listed ahead. Such side effects of Arvast CF Capsule DR normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Arvast CF Capsule DR has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Arvast CF Capsule DR's effects on the liver, heart and kidney are discussed below in the Arvast CF Capsule DR related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Arvast CF Capsule DR since this can cause severe adverse effects.
Besides this, Arvast CF Capsule DR may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arvast CF Capsule DR is considered not safe while driving, and is not addictive.
Arvast CF Capsule DR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Arvast CF Capsule DR safe for pregnant women?
Arvast CF can have harmful effects in pregnant women. If you experience any discomfort after using Arvast CF, then discontinue the use and take your doctor's advice.
Is the use of Arvast CF Capsule DR safe during breastfeeding?
Arvast CF can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Arvast CF Capsule DR on the Kidneys?
Arvast CF has very mild side effects on the kidneys.
What is the effect of Arvast CF Capsule DR on the Liver?
Arvast CF has very mild side effects on the liver.
What is the effect of Arvast CF Capsule DR on the Heart?
The heart can be affected by Arvast CF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Arvast CF Capsule DR unless your doctor advises you to do so -
Is this Arvast CF Capsule DR habit forming or addictive?
No, there is no any evidence that Arvast CF Capsule DR is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Arvast CF Capsule DR. So it is best to avoid driving.
Is it safe?
Arvast CF Capsule DR should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Arvast CF Capsule DR is not used to treat mental disorders.
Interaction between Food and Arvast CF Capsule DR
There is no information on the effects of taking Arvast CF Capsule DR with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Arvast CF Capsule DR
No research has been done on this till date. Therefore, it is not known what the effect of taking Arvast CF Capsule DR with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650